Pipeline
Our focus on new product development for musculoskeletal pain and pain adjacencies is motivated by the significant need for innovation in this space.
Developing better solutions to pain relief
We refuse to settle for therapies that are just “good enough” – patients deserve better solutions that will not only help them get back to normal, but stay normal for longer. We believe Better is Possible, and we are pursuing innovative solutions that will offer exponential improvements in pain relief and durability.
Beyond expanding applications and indications for our existing products, we are leveraging cutting-edge technologies, such as gene therapy, to reach and transform the lives of even more patients.
Better
is Possible.
PCRX-201: Unlocking gene therapy to address pain
Osteoarthritis of the knee (OAK) is a serious disease in desperate need for innovation. PCRX-201 (enekinragene inzadenovec) is a gene therapy specifically designed to inhibit activation of inflammation caused by this disease and deliver more durable pain relief.
Let’s innovate together
Collaboration drives progress, and we’re proud to work with organizations that share our vision for advancing pain management.